Combining αGITR antibodies with ICBs resulted in stronger survival benefits in mouse models of human glioblastoma brain cancer.
A new study identifies a possible genetic mechanism that causes a quicker progression of multiple sclerosis. The absence of Tob1 in CD4+ T cells is key to early onset of a more aggressive form of MS.
